Cargando…

A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale

Detalles Bibliográficos
Autores principales: Saxena, Snigdha, Arora, Pooja, Sardana, Kabir, Muddebihal, Aishwarya, Sachdeva, Soumya, Ahuja, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792049/
https://www.ncbi.nlm.nih.gov/pubmed/36578704
http://dx.doi.org/10.4103/ijd.ijd_818_21
_version_ 1784859549848567808
author Saxena, Snigdha
Arora, Pooja
Sardana, Kabir
Muddebihal, Aishwarya
Sachdeva, Soumya
Ahuja, Arvind
author_facet Saxena, Snigdha
Arora, Pooja
Sardana, Kabir
Muddebihal, Aishwarya
Sachdeva, Soumya
Ahuja, Arvind
author_sort Saxena, Snigdha
collection PubMed
description
format Online
Article
Text
id pubmed-9792049
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-97920492022-12-27 A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale Saxena, Snigdha Arora, Pooja Sardana, Kabir Muddebihal, Aishwarya Sachdeva, Soumya Ahuja, Arvind Indian J Dermatol Correspondences Wolters Kluwer - Medknow 2022 /pmc/articles/PMC9792049/ /pubmed/36578704 http://dx.doi.org/10.4103/ijd.ijd_818_21 Text en Copyright: © 2022 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Correspondences
Saxena, Snigdha
Arora, Pooja
Sardana, Kabir
Muddebihal, Aishwarya
Sachdeva, Soumya
Ahuja, Arvind
A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title_full A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title_fullStr A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title_full_unstemmed A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title_short A Rarely Employed Therapeutic Pearl of Split-Dose Oral Corticosteroid in Severe Type 2 or Erythema Nodosum Leprosum Reaction in Lepromatous Leprosy and its Therapeutic Rationale
title_sort rarely employed therapeutic pearl of split-dose oral corticosteroid in severe type 2 or erythema nodosum leprosum reaction in lepromatous leprosy and its therapeutic rationale
topic Correspondences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792049/
https://www.ncbi.nlm.nih.gov/pubmed/36578704
http://dx.doi.org/10.4103/ijd.ijd_818_21
work_keys_str_mv AT saxenasnigdha ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT arorapooja ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT sardanakabir ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT muddebihalaishwarya ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT sachdevasoumya ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT ahujaarvind ararelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT saxenasnigdha rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT arorapooja rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT sardanakabir rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT muddebihalaishwarya rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT sachdevasoumya rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale
AT ahujaarvind rarelyemployedtherapeuticpearlofsplitdoseoralcorticosteroidinseveretype2orerythemanodosumleprosumreactioninlepromatousleprosyanditstherapeuticrationale